DOI QR코드

DOI QR Code

Effects of resveratrol on the inflammatory response and renal injury in hyperuricemic rats

  • Xiao, Benxi (Department of Nutrition, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences) ;
  • Ma, Wenjun (Department of Nutrition, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences) ;
  • Zheng, Ying (Department of Nutrition, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences) ;
  • Li, Zhen (Department of Nutrition, School of Public Health in Sun Yat-sen University) ;
  • Li, Dan (Department of Nutrition, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences) ;
  • Zhang, Yanjun (Department of Nutrition, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences) ;
  • Li, Yuanhong (Department of Nutrition, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences) ;
  • Wang, Duan (Department of Nutrition, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences)
  • Received : 2020.03.20
  • Accepted : 2020.07.16
  • Published : 2021.02.01

Abstract

BACKGROUND/OBJECTIVES: Hyperuricemic nephropathy is a common cause of acute kidney injury. Resveratrol can ameliorate kidney injury, but the explicit mechanism remains unclear. We investigated the effects of resveratrol on the inflammatory response and renal injury in hyperuricemic rats. MATERIALS/METHODS: A rat model of hyperuricemic nephropathy was established by the oral administration of a mixture of adenine and potassium oxinate. Biochemical analysis and hematoxylin and eosin staining were performed to assess the rat kidney function. Enzyme-linked immunosorbent assays were performed to evaluate the immune and oxidative responses. RESULTS: The expression levels of urine albumin and β2-microglobulin were significantly decreased after resveratrol treatment. In addition, the levels of serum creatinine and uric acid were significantly decreased in the resveratrol groups, compared with the control group. The levels of proinflammatory factors, such as interleukin-1β and tumor necrosis factor-α, in kidney tissue and serum were also increased in the hyperuricemic rats, and resveratrol treatment inhibited their expression. Moreover, the total antioxidant capacity in kidney tissue as well as the superoxide dismutase and xanthine oxidase levels in serum were all decreased by resveratrol treatment. CONCLUSIONS: Resveratrol may protect against hyperuricemic nephropathy through regulating the inflammatory response.

Keywords

References

  1. Adedeji AO, Pourmohamad T, Chen Y, Burkey J, Betts CJ, Bickerton SJ, Sonee M, McDuffie JE. Investigating the value of urine volume, creatinine, and cystatin C for urinary biomarkers normalization for drug development studies. Int J Toxicol 2019;38:12-22. https://doi.org/10.1177/1091581818819791
  2. Fidan C, Kantar A, Baskin E, Gulleroglu K, Akdur A, Moray G, Haberal M. Effects of hyperuricemia on renal function in pediatric renal transplant recipients. Exp Clin Transplant 2015;13 Suppl 1:247-50.
  3. Ghei M, Mihailescu M, Levinson D. Pathogenesis of hyperuricemia: recent advances. Curr Rheumatol Rep 2002;4:270-4. https://doi.org/10.1007/s11926-002-0076-z
  4. Lim AY, Teng GG. Allopurinol: a necessary evil. Singapore Med J 2009;50:925-6.
  5. Zhang W, Chen H, Sun C, Wu B, Bai B, Liu H, Shan X, Liang G, Zhang Y. A novel resveratrol analog PA19 attenuates obesity-induced cardiac and renal injury by inhibiting inflammation and inflammatory cell infiltration. Mol Med Rep 2019;19:4770-8.
  6. Pan QR, Ren YL, Zhu JJ, Hu YJ, Zheng JS, Fan H, Xu Y, Wang G, Liu WX. Resveratrol increases nephrin and podocin expression and alleviates renal damage in rats fed a high-fat diet. Nutrients 2014;6:2619-31. https://doi.org/10.3390/nu6072619
  7. Kitada M, Koya D. Renal protective effects of resveratrol. Oxid Med Cell Longev 2013;2013:568093.
  8. Shi YW, Wang CP, Liu L, Liu YL, Wang X, Hong Y, Li Z, Kong LD. Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice. Mol Nutr Food Res 2012;56:1433-44. https://doi.org/10.1002/mnfr.201100828
  9. Kitada M, Kume S, Imaizumi N, Koya D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 2011;60:634-43. https://doi.org/10.2337/db10-0386
  10. Chen YH, Fu YC, Wu MJ. Does resveratrol play a role in decreasing the inflammation associated with contrast induced nephropathy in rat model? J Clin Med 2019;8:147. https://doi.org/10.3390/jcm8020147
  11. Wu M, Gu J, Mei S, Xu D, Jing Y, Yao Q, Chen M, Yang M, Chen S, Yang B, Qi N, Hu H, Wuthrich RP, Mei C. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation. Nephrol Dial Transplant 2016;31:1826-34. https://doi.org/10.1093/ndt/gfw058
  12. Huang DD, Shi G, Jiang Y, Yao C, Zhu C. A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomed Pharmacother 2020;125:109767. https://doi.org/10.1016/j.biopha.2019.109767
  13. Den Hartogh DJ, Tsiani E. Health benefits of resveratrol in kidney disease: evidence from in vitro and in vivo studies. Nutrients 2019;11:11. https://doi.org/10.3390/nu11010011
  14. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006;5:493-506. https://doi.org/10.1038/nrd2060
  15. Zhu W, Pang M, Dong L, Huang X, Wang S, Zhou L. Anti-inflammatory and immunomodulatory effects of iridoid glycosides from Paederia scandens (LOUR.) MERRILL (Rubiaceae) on uric acid nephropathy rats. Life Sci 2012;91:369-76. https://doi.org/10.1016/j.lfs.2012.08.013
  16. Chen L, Yang S, Zumbrun EE, Guan H, Nagarkatti PS, Nagarkatti M. Resveratrol attenuates lipopolysaccharide-induced acute kidney injury by suppressing inflammation driven by macrophages. Mol Nutr Food Res 2015;59:853-64. https://doi.org/10.1002/mnfr.201400819
  17. Luo CJ, Luo F, Bu QD, Jiang W, Zhang W, Liu XM, Che L, Luan H, Zhang H, Ma RX, Sun JP, Xu Y. Protective effects of resveratrol on acute kidney injury in rats with sepsis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2020;164:49-56. https://doi.org/10.5507/bp.2019.006
  18. Wang N, Mao L, Yang L, Zou J, Liu K, Liu M, Zhang H, Xiao X, Wang K. Resveratrol protects against early polymicrobial sepsis-induced acute kidney injury through inhibiting endoplasmic reticulum stress-activated NF-κB pathway. Oncotarget 2017;8:36449-61. https://doi.org/10.18632/oncotarget.16860
  19. Gan Y, Tao S, Cao D, Xie H, Zeng Q. Protection of resveratrol on acute kidney injury in septic rats. Hum Exp Toxicol 2017;36:1015-22. https://doi.org/10.1177/0960327116678298
  20. Wang Y, Feng F, Liu M, Xue J, Huang H. Resveratrol ameliorates sepsis-induced acute kidney injury in a pediatric rat model via Nrf2 signaling pathway. Exp Ther Med 2018;16:3233-40.
  21. Bekpinar S, Karaca E, Yamakoglu S, Alp-Yildirim FI, Olgac V, Uydes-Dogan BS, Cibali E, Gultepe S, Uysal M. Resveratrol ameliorates the cyclosporine-induced vascular and renal impairments: possible impact of the modulation of renin-angiotensin system. Can J Physiol Pharmacol 2019;97:1115-23. https://doi.org/10.1139/cjpp-2018-0753
  22. Xue HY, Yuan L, Cao YJ, Fan YP, Chen XL, Huang XZ. Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation. Biosci Rep 2016;36:e00339. https://doi.org/10.1042/BSR20160035
  23. Smith NC, Christian SL, Taylor RG, Santander J, Rise ML. Immune modulatory properties of 6-gingerol and resveratrol in Atlantic salmon macrophages. Mol Immunol 2018;95:10-9. https://doi.org/10.1016/j.molimm.2018.01.004
  24. Erkasap S, Erkasap N, Bradford B, Mamedova L, Uysal O, Ozkurt M, Ozyurt R, Kutlay O, Bayram B. The effect of leptin and resveratrol on JAK/STAT pathways and Sirt-1 gene expression in the renal tissue of ischemia/reperfusion induced rats. Bratisl Lek Listy (Tlacene Vyd) 2017;118:443-8.
  25. Li J, Li L, Wang S, Zhang C, Zheng L, Jia Y, Xu M, Zhu T, Zhang Y, Rong R. Resveratrol alleviates inflammatory responses and oxidative stress in rat kidney ischemia-reperfusion injury and H2O2-Induced NRK-52E Cells via the Nrf2/TLR4/NF-κB Pathway. Cell Physiol Biochem 2018;45:1677-89. https://doi.org/10.1159/000487735
  26. Bienholz A, Mae Pang R, Guberina H, Rauen U, Witzke O, Wilde B, Petrat F, Feldkamp T, Kribben A. Resveratrol does not protect from ischemia-induced acute kidney injury in an in vivo rat model. Kidney Blood Press Res 2017;42:1090-103. https://doi.org/10.1159/000485606
  27. He T, Guan X, Wang S, Xiao T, Yang K, Xu X, Wang J, Zhao J. Resveratrol prevents high glucose-induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway. Mol Cell Endocrinol 2015;402:13-20. https://doi.org/10.1016/j.mce.2014.12.010
  28. Wang Y, Wang B, Qi X, Zhang X, Ren K. Resveratrol protects against post-contrast acute kidney injury in rabbits with diabetic nephropathy. Front Pharmacol 2019;10:833. https://doi.org/10.3389/fphar.2019.00833
  29. Ramalingam A, Santhanathas T, Shaukat Ali S, Zainalabidin S. Resveratrol supplementation protects against nicotine-induced kidney injury. Int J Environ Res Public Health 2019;16:16. https://doi.org/10.3390/ijerph16010016
  30. Hall S, Dixit M, Arany I. Resveratrol attenuates nicotine-mediated oxidative injury by inducing manganese superoxide dismutase in renal proximal tubule cells. In Vivo 2017;31:551-5. https://doi.org/10.21873/invivo.11093
  31. Soussi D, Danion J, Baulier E, Favreau F, Sauvageon Y, Bossard V, Matillon X, Turpin F, Belgsir EM, Thuillier R, Hauet T. Vectisol formulation enhances solubility of resveratrol and brings its benefits to kidney transplantation in a preclinical porcine model. Int J Mol Sci 2019;20:2268. https://doi.org/10.3390/ijms20092268
  32. Ibrahim A, Al-Hizab FA, Abushouk AI, Abdel-Daim MM. Nephroprotective effects of benzyl isothiocyanate and resveratrol against cisplatin-induced oxidative stress and inflammation. Front Pharmacol 2018;9:1268. https://doi.org/10.3389/fphar.2018.01268
  33. Cigremis Y, Akgoz M, Ozen H, Karaman M, Kart A, Gecer M, Atalan G. Resveratrol ameliorates cisplatininduced oxidative injury in New Zealand rabbits. Can J Physiol Pharmacol 2015;93:727-35. https://doi.org/10.1139/cjpp-2014-0420
  34. Denek Z, Erbil G, Ozbal S, Micili SC, Ozogul C. The effects of resveratrol against trifluralin toxicity in the urinary tract of rats. Toxicol Ind Health 2016;32:106-17. https://doi.org/10.1177/0748233713498437
  35. Al Dera HS. Protective effect of resveratrol against aluminum chloride induced nephrotoxicity in rats. Saudi Med J 2016;37:369-78. https://doi.org/10.15537/smj.2016.4.13611